Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial by James, Nicholas D, Prof, Sydes, Matthew R, CSci, Mason, Malcolm D, Prof, Clarke, Noel W, Prof, Anderson, John, MD, Dearnaley, David P, Prof, Dwyer, John, FRIC, Jovic, Gordana, PhD, Ritchie, Alastair WS, FRCSEd, Russell, J Martin, FRCR, Sanders, Karen, BSc, Thalmann, George N, Prof, Bertelli, Gianfilippo, MD, Birtle, Alison J, FRCR, O'Sullivan, Joe M, Prof, Protheroe, Andrew, PhD, Sheehan, Denise, FRCR, Srihari, Narayanan, FRCR, Parmar, Mahesh KB, Prof

Get full text